Varicella Vaccine: a Molecular Variant That May Contribute to Attenuation. [PDF]
Gershon AA, Gershon MD.
europepmc +1 more source
Insights From Studies of the Genetics, Pathogenesis, and Immunogenicity of the Varicella Vaccine. [PDF]
Arvin AM.
europepmc +1 more source
A Case of Aseptic Meningitis Without Rash Possibly Associated With Varicella Vaccine. [PDF]
Aoki Y +3 more
europepmc +1 more source
Safety, immunogenicity, and effectiveness of the MAV/06 varicella vaccine: A comprehensive review of a new strain vaccine. [PDF]
Shin Y +5 more
europepmc +1 more source
Immunogenicity and Safety of a Newly Developed Live Attenuated Varicella Vaccine in Healthy Children: A Multi-National, Randomized, Double-Blinded, Active-Controlled, Phase 3 Study. [PDF]
Choi UY +13 more
europepmc +1 more source
Post-Marketing Surveillance Study of the Live Attenuated Varicella Vaccine (SKYVaricella Inj.) in Korean Children. [PDF]
Kim H, Kim K, Kim HY.
europepmc +1 more source
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling. [PDF]
Suh J, Choi JK, Lee J, Park SH.
europepmc +1 more source
Varicella Vaccine Effectiveness and Duration of Protection: A Systematic Review and Meta-Analysis. [PDF]
Bolormaa E, Lee YH, Choe YJ, Choe SA.
europepmc +1 more source
Effectiveness of varicella vaccine as post-exposure prophylaxis: a meta-analysis. [PDF]
Chen D, Li Y, Wu Q.
europepmc +1 more source
Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4-6 years: A phase II, randomized, multi-country trial. [PDF]
Habib MA +9 more
europepmc +1 more source

